![BrainChild Bio spins out of Seattle Children’s to develop cancer drugs](https://www.biopharmadive.com/imgproxy/u-tufyI9C0QNFqDz9WRWNFNsTmksAsEZu8KkXL29Bzw/g:ce/rs:fill:770:435:0/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTE0ODAzNjc0MTguanBn.jpg)
BrainChild Bio spins out of Seattle Children’s to develop cancer drugs
Dive Brief: Seattle Children’s Hospital is spinning out a biotechnology startup named BrainChild Bio to develop new cancer drugs for central nervous system tumors, the hospital announced Tuesday. The company is licensing CAR-T technology from Seattle Children’s, and has also received equity funding from the health care provider. Financial terms of the deal were not…